# Idiopathic Pulmonary Fibrosis: Analysis of Predisposing Variants in Patients with Familial Forms

**Authors:** Ilaria Stanghellini, Elena Bonora, Marco Sebastiani, Carlo Salvarani, Filippo Gozzi, Dario Andrisani, Roberto Tonelli, Nicola Rizzardi, Christian Bergamini, Federica Isidori, Marco Seri, Enrico Clini, Stefania Cerri, Olga Calabrese

PMC · DOI: 10.3390/biomedicines14010138 · Biomedicines · 2026-01-09

## TL;DR

This study investigates genetic variants in patients with familial pulmonary fibrosis, identifying copy number variations and new mutations that may contribute to the disease.

## Contribution

The study introduces the use of CGH-SNP array to detect copy number variations in IPF and reports a novel SNP variant.

## Key findings

- 17 out of 37 patients had copy number variations (CNVs) linked to IPF-related mechanisms.
- A novel SNP variant rs141420125 was detected in 62% of patients.
- Mosaic Y chromosome deletions and runs of homozygosity were observed in 13.5% of patients each.

## Abstract

Background: idiopathic pulmonary fibrosis (IPF) causes progressive and irreversible changes in the lung parenchyma, leading to respiratory failure. Its pathogenesis involves several damage/repair mechanisms leading to fibrosis, whilst alterations of genes implicated in these processes contribute to the development of the disease. At present, next-generation sequencing (NGS) analyses investigate single-nucleotide or small indel variants, and no evaluation of genomic rearrangements has been so far reported. Methods: In order to identify predisposing variants, we analyzed—both by NGS and by comparative genomic hybridization/single-nucleotide polymorphism (CGH-SNP array) array—37 patients with a diagnosis of familial pulmonary fibrosis. Results: a total of 17 patients (46%) harbored copy number variations (CNVs), 10 (27%) did not harbor any CNVs, 5 (13.5%) showed a mosaic deletion of the Y chromosome, and 5 (13.5%) showed a run of homozygosity (ROH). NGS identified causative variants (including a novel one) in five patients (5/37, 13.5%) and confirmed the high prevalence of MUC5B promoter polymorphism rs35705950, including the detection of a previously unreported form in IPF SNP (indicated as “novel” in the main text), rs141420125 (23/37; 62%). Conclusions: CGH-SNP array identified CNVs containing genes involved in mechanisms (i.e., oxidative stress, mitophagy, NF-Kb pathway) that have been shown to play a role in the pathogenesis of IPF. Therefore, the application of CGH-SNP array or other quantitative tests should be considered in the diagnostic setup of these patients

## Linked entities

- **Genes:** MUC5B (mucin 5B, oligomeric mucus/gel-forming) [NCBI Gene 727897]
- **Diseases:** idiopathic pulmonary fibrosis (MONDO:0800029), pulmonary fibrosis (MONDO:0002771)

## Full-text entities

- **Genes:** MUC5B (mucin 5B, oligomeric mucus/gel-forming) [NCBI Gene 727897] {aka MG1, MUC-5B, MUC5, MUC9}
- **Diseases:** IPF (MESH:D054990), respiratory failure (MESH:D012131), fibrosis (MESH:D005355)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs141420125, rs35705950

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12838683/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12838683/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12838683/full.md

---
Source: https://tomesphere.com/paper/PMC12838683